Literature DB >> 19589400

Psychometric properties of the French translation of the reduced KOOS and HOOS (KOOS-PS and HOOS-PS).

P Ornetti1, A V Perruccio, E M Roos, L S Lohmander, A M Davis, J F Maillefert.   

Abstract

OBJECTIVE: To evaluate the psychometric properties of the French KOOS physical function (KOOS-PS) and HOOS physical function (HOOS-PS), specifically its feasibility, reliability, construct validity, and responsiveness.
METHODS: Consecutive outpatients consulting for primary knee or hip osteoarthritis (OA) in a rheumatology department were included. During the initial assessment, patients were asked to complete the Knee injury and Osteoarthritis Outcome Score (KOOS) or Hip disability and Osteoarthritis Outcome Score (HOOS) questionnaire and the OsteoArthritis Knee and Hip Quality Of Life questionnaire (OAKHQOL). The patients were given a second KOOS or HOOS questionnaire to complete and return by mail 2 weeks later. Feasibility was assessed by calculating the percentage of missing items and the floor and ceiling effects. Test-retest reliability was evaluated using the intra-class correlation coefficient (ICC). Convergent and divergent construct validity was determined by comparing the results of the KOOS-PS or HOOS-PS and OAKHQOL questionnaires using Spearman's rank test. Responsiveness was evaluated using data obtained in other hip or knee OA patients prior to and 1 month after intra-articular hyaluronic acid injection, using standardized response mean (SRM) and effect-size (ES).
RESULTS: Eighty-seven patients with knee OA and 50 hip OA patients were included. The KOOS-PS and HOOS-PS scores were obtained for all patients as there were no missing items. Neither a floor nor a ceiling effect was observed. The ICC of KOOS-PS and HOOS-PS was 0.861 (0.763-0.921) and 0.859 (0.725-0.929), respectively. A strong or moderate correlation was observed, as expected, between KOOS-PS, HOOS-PS, and the OAKHQOL physical activities, pain, and mental health domains. A weak correlation was observed, as expected, between KOOS-PS, HOOS-PS, and the other OAKHQOL domains, except for a moderate correlation between the KOOS-PS and social functioning. The responsiveness was demonstrated with SRM and ES of 0.80 and 0.51 (KOOS-PS), 1.10 and 0.62 (HOOS-PS), respectively.
CONCLUSION: The French versions of KOOS-PS and HOOS-PS are reliable, valid, and responsive questionnaires for capturing functional disability in people with knee and hip OA.

Entities:  

Mesh:

Year:  2009        PMID: 19589400     DOI: 10.1016/j.joca.2009.06.007

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  10 in total

1.  Cross-cultural adaptation and validation of the Turkish version of the Hip disability and Osteoarthritis Outcome Score-Physical function Short-form (HOOS-PS).

Authors:  Ozlem Yilmaz; Ebru Demir Gul; Hatice Bodur
Journal:  Rheumatol Int       Date:  2013-09-12       Impact factor: 2.631

Review 2.  Patient-Reported Measures of Physical Function in Knee Osteoarthritis.

Authors:  Daniel K White; Hiral Master
Journal:  Rheum Dis Clin North Am       Date:  2016-03-17       Impact factor: 2.670

3.  Reliability and clinically important improvement thresholds for osteoarthritis pain and function scales: a multicenter study.

Authors:  Jasvinder A Singh; Ruili Luo; Glenn C Landon; Maria Suarez-Almazor
Journal:  J Rheumatol       Date:  2014-01-15       Impact factor: 4.666

Review 4.  Measures of knee function: International Knee Documentation Committee (IKDC) Subjective Knee Evaluation Form, Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Injury and Osteoarthritis Outcome Score Physical Function Short Form (KOOS-PS), Knee Outcome Survey Activities of Daily Living Scale (KOS-ADL), Lysholm Knee Scoring Scale, Oxford Knee Score (OKS), Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Activity Rating Scale (ARS), and Tegner Activity Score (TAS).

Authors:  Natalie J Collins; Devyani Misra; David T Felson; Kay M Crossley; Ewa M Roos
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

5.  Total knee arthroplasty in patients with varus deformities greater than ten degrees: survival analysis at a mean ten year follow-up.

Authors:  Benjamin Puliero; Henri Favreau; David Eichler; Philippe Adam; François Bonnomet; Matthieu Ehlinger
Journal:  Int Orthop       Date:  2018-06-21       Impact factor: 3.075

6.  Knee osteoarthritis in professional football is related to severe knee injury and knee surgery.

Authors:  Vincent Gouttebarge; Haruhito Aoki; Gino M M J Kerkhoffs
Journal:  Inj Epidemiol       Date:  2018-06-18

7.  Is the Pelvis-Thorax Coordination a Valuable Outcome Instrument to Assess Patients With Hip Osteoarthritis?

Authors:  Florent Moissenet; Alexandre Naaim; Paul Ornetti; Abderrahmane Bourredjem; Christine Binquet; Claire Morisset; Anais Gouteron; Jean-Francis Maillefert; Davy Laroche
Journal:  Front Bioeng Biotechnol       Date:  2020-01-23

8.  Mapping and Crosswalk of the Oxford Hip Score and Different Versions of the Hip Disability and Osteoarthritis Outcome Score.

Authors:  Sophie Putman; Cristian Preda; Julien Girard; Alain Duhamel; Henri Migaud
Journal:  Clin Orthop Relat Res       Date:  2021-07-01       Impact factor: 4.755

9.  Extending the use of PROMs in the NHS--using the Oxford Knee Score in patients undergoing non-operative management for knee osteoarthritis: a validation study.

Authors:  Kristina K Harris; Jill Dawson; Luke D Jones; David J Beard; Andrew J Price
Journal:  BMJ Open       Date:  2013-08-21       Impact factor: 2.692

10.  Monitoring the health of transitioning professional footballers: protocol of an observational prospective cohort study.

Authors:  Vincent Gouttebarge; Thor Einar Andersen; Charlotte Cowie; Edwin Goedhart; Harald Jorstad; Simon Kemp; Marsh Königs; Mario Maas; Emmanuel Orhant; Jussi Rantanen; Jari Salo; Luis Serratosa; Keith Stokes; Johannes L Tol; Evert Verhagen; Alexis Weber; Gino Kerkhoffs
Journal:  BMJ Open Sport Exerc Med       Date:  2019-12-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.